O30: REKLAIM: A first in human phase Ib clinical trial of FBX-101 (AAVrh10.GALC) intravenously administered after UCBT for infantile Krabbe disease
Main Authors: | Maria Escolar, Mark Vander Lugt, Raymond Wang, Juan Ruiz, Michele Poe, Paul Szabolcs |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-01-01
|
Series: | Genetics in Medicine Open |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2949774424000219 |
Similar Items
-
P014: First-in-human phase 1/2 trial of intravenous FBX-101 with cord blood transplantation increases GALC, brain and motor development in infantile Krabbe
by: Maria Escolar, et al.
Published: (2023-01-01) -
Array CGH improves detection of mutations in the <it>GALC</it> gene associated with Krabbe disease
by: Tanner Alice K, et al.
Published: (2012-06-01) -
Pathogenic Variants in GALC Gene Correlate With Late Onset Krabbe Disease and Vision Loss: Case Series and Review of Literature
by: Nicholas A. Bascou, et al.
Published: (2020-10-01) -
GALC mutations in Chinese patients with late-onset Krabbe disease: a case report
by: Shunzhi Zhuang, et al.
Published: (2019-06-01) -
rAAV2-Mediated Restoration of GALC in Neural Stem Cells from Krabbe Patient-Derived iPSCs
by: Guoshuai Tian, et al.
Published: (2023-04-01)